Veritable’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Veritable’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-3,887	Closed	-$439K	–	718
2015 Q4	$439K	Hold	3,887	–	–	0.01%	496
2015 Q3	$394K	Hold	3,887	–	–	0.01%	511
2015 Q2	$482K	Hold	3,887	–	–	0.01%	468
2015 Q1	$460K	Hold	3,887	–	–	0.01%	626
2014 Q4	$397K	Buy	3,887 +1,561	+67%	+$152K	0.01%	664
2014 Q3	$213K	Buy	+2,326	New	+$202K	﹤0.01%	888

Other funds holding FBT

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Veritable's FBT Position: Q1 2016 in Review

Veritable sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q1 2016, closing a stake of 3,887 shares — an estimated $439K sold.

Veritable first reported a position in FBT in Q3 2014 and held it in 6 quarters. The position peaked at $482K in Q2 2015. 107 funds tracked by Wall St. Rank hold FBT as of Q1 2016.

Veritable reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q1 2016 after selling out during the quarter.
Veritable sold 3,887 First Trust NYSE Arca Biotechnology Index Fund shares in Q1 2016, an estimated $439K.
Veritable first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q3 2014 and held it in 6 quarters.
Veritable's First Trust NYSE Arca Biotechnology Index Fund position peaked at $482K in Q2 2015.
107 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q1 2016.

Based on Veritable's 13F filing for Q1 2016, filed 16 May 2016.